Positive Target of MRI: Could It be a Key Predictive Factor in Upgrading of Prostate Cancer Risk?
Researchers found that a positive target of MRI led to a threefold increased risk for Gleason Grading Group (GGG) upgrading after radical prostatectomy in patients with low prostate cancer risk.
Claustrophobia in Magnetic Resonance Imaging: An Analysis of Causes, Impacts and Solutions
January 18th 2024Given the frequent challenges in magnetic resonance imaging that are associated with claustrophobia, this author discusses innovations in noise reduction, radiofrequency coils and wide bore scanners, and emphasizes keys to relieving patient anxiety.
FDA Clears AI-Powered CT Assessment Tool for Lung Fibrosis
For patients with suspected interstitial lung disease, the digital biomarker solution Fibresolve offers machine learning capability of diagnosing idiopathic pulmonary fibrosis (IPF) based on assessment of lung computed tomography (CT) scans.
Newly FDA-Cleared Stereotactic System Can be Utilized with Pre-Op MRI or CT
Utilized for neurological procedures including biopsies, catheter placement and electrode introduction, the SmartFrame OR Stereotactic System can be combined with preoperative MRI or CT to ensure optimal placement of devices and instruments.
Study: PSMA PET/CT Identifies 18 Percent More Metastatic Renal Cancers than Conventional Imaging
January 15th 2024In addition to detecting more than double the number of distant lymph nodes and distant lesions in comparison to conventional imaging with computed tomography (CT), PSMA PET/CT reportedly changed management for 32 percent of patients.
Patent Battle Brewing Between Novartis, Lantheus Over Generic Lutathera Radioligand Therapy
January 12th 2024The FDA has accepted Lantheus' abbreviated new drug application for a generic Lutathera, just months after Novartis announced positive phase 3 data supporting a first-line indication for the radiopharmaceutical in neuroendocrine tumors.
Current Insights on Differentiating Pulmonary Subsolid Nodules with Non-Contrast CT
Patients with benign pulmonary absorbable subsolid nodules (AB-SSNs) have a greater frequency of nodules in comparison to those with non-absorbable benign subsolid nodules (NB-SSNs) and patients with malignant subsolid nodules (M-SSNs), according to a recent study of follow-up non-contrast CT exams in over 400 patients.
Noting the challenges with angiography in the imaging of lower extremity revascularization, a panel of interventional radiologists, interventional cardiologists and vascular surgeons discussed emerging evidence that supports the use of intravascular ultrasound in facilitating improved outcomes in this high-risk patient population.
In part of an ongoing multicenter study evaluating commercial artificial intelligence (AI) products in radiology, AI lung nodule detection software from four out of seven vendors demonstrated stand-alone AUCs ranging from 5 to 12 percent higher than the mean AUC of 17 reviewing radiologists.
FDA Clears AI-Powered Bladder Volume Measurement for Handheld Ultrasound
Offering enhanced utility for assessing urinary incontinence, bladder emptying and urinary retention, the Clarius Bladder AI ultrasound software reportedly provides bladder volume measurement in seconds.